MIAMI, Aug. 12, 2022 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a biopharmaceutical company focused on developing novel medicines for COVID-19 and other viral and ARDS-related diseases and for the management of breast and prostate cancers, today announced the granting of inducement awards to five new employees. In accordance with NASDAQ Listing Rule 5635(c)(4), the award was made as a material inducement to the five employees’ entry into employment with the Company.
See the rest here:
Veru Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Recommendation and review posted by Fredricko
